Xref and Immutep surge as growth and biotech lead Week 16

• Xref, Immutep and Zip led the week’s biggest moves as investors chased growth, drug news and upgraded earnings guidance.
• a2 Milk was the standout faller after supply delays in China forced a weaker full-year outlook.
• Resources remained active, with strong interest in gold, uranium, rare earths and graphite projects backed by studies or drilling.
• Takeovers and merger votes kept rolling through, from Insignia and National Storage REIT to African Gold and DUI.